Core Viewpoint - Rosen Law Firm is reminding investors who purchased Dow Inc. securities between January 30, 2025, and July 23, 2025, of the October 28, 2025, lead plaintiff deadline for a class action lawsuit [1] Group 1: Class Action Details - Investors who purchased Dow securities during the specified Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [1] - A class action lawsuit has already been filed, and those wishing to serve as lead plaintiff must act by October 28, 2025 [2] - The lawsuit alleges that Dow made false and misleading statements regarding its ability to manage macroeconomic and tariff-related challenges, overstating its financial flexibility and downplaying the negative impacts on its business [4] Group 2: Rosen Law Firm's Credentials - Rosen Law Firm emphasizes the importance of selecting qualified counsel with a successful track record in securities class actions, highlighting its own achievements in this area [3] - The firm has secured significant settlements for investors, including over $438 million in 2019 alone, and has been consistently ranked among the top firms for securities class action settlements [3]

Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against Tronox Holdings plc due to significant financial losses reported by the company, particularly related to its TiO2 sales and overall revenue projections [1][3][4]. Financial Performance - Tronox announced a significant reduction in TiO2 sales for Q2 2025, attributing the decline to a softer coatings season and increased competition [4]. - Following the announcement, Tronox revised its full-year revenue guidance downward and reduced its dividend by 60% [4]. Stock Market Reaction - Tronox's stock price experienced a dramatic decline, falling from $5.14 per share on July 30, 2025, to $3.19 per share on July 31, 2025, marking a decrease of approximately 38% in just one day [5]. Legal Proceedings - A federal securities class action has been filed against Tronox, with a deadline of November 3, 2025, for investors to seek the role of lead plaintiff [1][6]. - The lead plaintiff is defined as the investor with the largest financial interest who directs the litigation on behalf of the class [6].

Group 1 - Berkshire Hathaway is officially acquiring Occidental's chemical business, OxyChem, in an all-cash deal valued at $9.7 billion [1] - Occidental currently has a debt load of approximately $22 billion and aims to reduce it to $15 billion [2] - Berkshire Hathaway is the largest shareholder in Occidental and this acquisition allows them to take full control of OxyChem [2] Group 2 - Following the announcement, Occidental's shares increased by just under 1%, with prior reports of the deal contributing to a rise in share prices over the last few days [3] - The CEO of Occidental, Vicky Haliburton, is expected to provide further insights in an upcoming live segment [3]

Core Viewpoint - A class action securities lawsuit has been filed against Dow Inc. alleging securities fraud that negatively impacted investors between January 30, 2025, and July 23, 2025 [1][2] Group 1: Allegations of Fraud - The lawsuit claims that Dow Inc. overstated its ability to manage macroeconomic and tariff-related challenges, as well as its financial flexibility to support dividends [2] - It is alleged that the true extent of negative impacts from competitive pressures, declining global sales, and product oversupply was understated [2] - Defendants' public statements are claimed to have been materially false and misleading throughout the relevant period [2] Group 2: Legal Process and Participation - Investors who suffered losses during the specified timeframe have until October 28, 2025, to request appointment as lead plaintiff, although participation in any recovery does not require this [3] - Class members may be entitled to compensation without incurring any out-of-pocket costs or fees [3] Group 3: Firm Background - Levi & Korsinsky has a history of securing significant settlements for shareholders and is recognized as one of the top securities litigation firms in the United States [4]

SINGAPORE--(BUSINESS WIRE)-- #BeachCleaning--Mitsui Chemicals Asia Pacific (MCAP) – In the early hours of 20 September 2025, a dedicated group of 15 employees from the affiliates in Singapore and their family members came together to make a tangible impact on the environment in celebration of World Cleanup Day. Partnering with sustainability-focused organization PLASTIFY, the team conducted a coastal cleanup that resulted in the collection of more than 145kg of trash. The cleanup effort, under the group's g ...

LOS ANGELES, Sept. 29, 2025 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP reminds investors of the upcoming October 28, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Dow Inc. (“Dow” or the “Company”) (NYSE: DOW) securities between January 30, 2025 and July 23, 2025, inclusive (the “Class Period”). IF YOU SUFFERED A LOSS ON YOUR DOW INVESTMENTS, CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS U ...

On 10/1/25, Air Products & Chemicals will trade ex-dividend, for its quarterly dividend of $1.79, payable on 11/10/25. As a percentage of APD's recent stock price of $266.78, this dividend works out to approximately 0.67%, so look for shares of Air Products & Chemicals Inc to trade 0.67% lower — all else being equal — when APD shares open for trading on 10/1/25. 10 Stocks Going Ex-Dividend »Below is a dividend history chart for APD, showing historical dividends prior to the most recent $1.79 declared by Air ...

Core Viewpoint - A securities class action lawsuit has been filed against Dow Inc. for allegedly making false and misleading statements regarding its financial condition and ability to manage macroeconomic challenges during the specified Class Period from January 30, 2025, to July 23, 2025 [1][3]. Group 1: Lawsuit Details - The lawsuit is on behalf of investors who purchased Dow securities during the Class Period, with a lead plaintiff deadline set for October 28, 2025 [1][4]. - The complaint alleges that Dow overstated its ability to mitigate macroeconomic and tariff-related headwinds, which negatively impacted its business and financial condition [3]. Group 2: Allegations Against Dow - The allegations include that Dow failed to disclose the true scope and severity of competitive and pricing pressures, softening global sales, and an oversupply of products in its markets [3]. - It is claimed that the public statements made by Dow were materially false and misleading throughout the Class Period [3]. Group 3: Legal Representation - Investors may seek to be appointed as lead plaintiff representatives through Kessler Topaz Meltzer & Check, LLP or choose to remain absent class members [4]. - The lead plaintiff will act on behalf of all class members and select counsel to represent the class in the litigation [4].

Core Points - Olin Corporation will review its third quarter 2025 financial results on October 28, 2025, at 9:00 a.m. Eastern time [1] - A press release with financial statements and segment information will be distributed after the market closes on October 27, 2025 [2] - The conference call will be accessible via toll-free numbers for U.S. and Canadian callers, and an international number for other participants, with a pass code required [3] - A replay of the conference call will be available for one year on the company's website, with a telephonic replay option for 7 days [4] Company Description - Olin Corporation is a leading vertically integrated global manufacturer and distributor of chemical products and a major U.S. manufacturer of ammunition [5] - The chemical products produced by Olin include chlorine, caustic soda, vinyls, epoxies, chlorinated organics, bleach, hydrogen, and hydrochloric acid [5] - Winchester, a division of Olin, produces and distributes various types of ammunition, including sporting, law enforcement, and military ammunition [5]

Group 1 - Morgan Stanley has crossed the 3% threshold in voting rights for Solvay, with a reported 3.13% after the transactions on September 18, 2025, and September 22, 2025 [1][5] - The total number of shares considered for the voting rights calculation is 105,876,416 [5] - The notifications indicate that the changes in voting rights were due to the acquisition or disposal of financial instruments treated as voting securities [5] Group 2 - Solvay is a leading chemical company with a history dating back to 1863, focusing on sustainable solutions across various sectors [3] - The company reported net sales of €4.7 billion in 2024 and employs approximately 9,000 people [3] - Solvay is committed to achieving a carbon-neutral future by 2050, emphasizing sustainability and innovation in its operations [3]